Gerresheimer AG (ETR: GXI)

Market Cap	2.75B
Revenue (ttm)	2.01B
Net Income (ttm)	114.30M
Shares Out	34.54M
EPS (ttm)	3.31
PE Ratio	24.08
Forward PE	14.61
Dividend	1.25 (1.57%)
Ex-Dividend Date	Jun 6, 2024

Volume	89,093
Open	80.65
Previous Close	81.10
Day's Range	76.65 - 80.75
52-Week Range	76.10 - 111.20
Beta	0.94
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 10, 2024

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufactu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1864
• Employees: 11,660
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: GXI

Financial Performance

In 2023, Gerresheimer AG's revenue was 1.99 billion, an increase of 9.54% compared to the previous year's 1.82 billion. Earnings were 116.13 million, an increase of 20.81%.